Serum Kynurenine Is a Novel Prognostic Factor in Patients with Hepatocellular Carcinoma

被引：0
|
作者：
Bekki, Shigemun [1 ]
Shimakura, Akane [1 ]
Kugiyama, Yuki [1 ]
Hashimoto, Satoru [1 ]
Saeki, Akira [1 ]
Nagaoka, Shinya [1 ]
Abiru, Seigo [1 ]
Yamasaki, Kazumi [1 ]
Komori, Atsumasa [1 ]
Yatsuhashi, Hiroshi [2 ]
机构：
[1] Natl Hosp Org, Clin Res Ctr, Nagasaki Med Ctr, Nagasaki, Japan
[2] Natl Hosp Org, Nagasaki Med Ctr, Nagasaki, Japan
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
889
引用
收藏
页码：521A / 522A
页数：2
相关论文
共 50 条
  • [21] Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma
    Yoshida, K
    Tomita, Y
    Okuda, Y
    Yamamoto, S
    Enomoto, H
    Uyama, H
    Ito, H
    Hoshida, Y
    Aozasa, K
    Nagano, H
    Sakon, M
    Kawase, I
    Monden, M
    Nakamura, H
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 159 - 167
  • [22] Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Hepatocellular Carcinoma
    Kenya Yoshida
    Yasuhiko Tomita
    Yorihide Okuda
    Shinji Yamamoto
    Hirayuki Enomoto
    Hirokazu Uyama
    Hiroaki Ito
    Yoshihiko Hoshida
    Katsuyuki Aozasa
    Hiroaki Nagano
    Masato Sakon
    Ichiro Kawase
    Morito Monden
    Hideji Nakamura
    Annals of Surgical Oncology, 2006, 13 : 159 - 167
  • [23] Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma
    Yang An
    Song Gao
    Wen-Chao Zhao
    Bao-An Qiu
    Nian-Xin Xia
    Peng-Jun Zhang
    Zhen-Ping Fan
    World Journal of Gastroenterology, 2018, (24) : 2596 - 2604
  • [24] Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma
    An, Yang
    Gao, Song
    Zhao, Wen-Chao
    Qiu, Bao-An
    Xia, Nian-Xin
    Zhang, Peng-Jun
    Fan, Zhen-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (24) : 2596 - 2604
  • [25] Serum levels of novel adipokines in patients with hepatocellular carcinoma
    Pazgan-Simon, M.
    Kukla, M.
    Zuwala-Jagiello, J.
    Grzebyk, E.
    Lekstan, A.
    Simon, K.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 129 - 129
  • [26] Is bile duct thrombi an prognostic factor for patients with hepatocellular carcinoma?
    Honda, G
    Ikai, I
    Yamamoto, Y
    Ozaki, N
    Yamauchi, K
    Sakai, Y
    Nakamura, H
    Shimahara, Y
    Yamaoka, Y
    HEPATOLOGY, 1997, 26 (04) : 1584 - 1584
  • [27] Hepatitis serology as a prognostic factor in patients with hepatocellular carcinoma.
    Ahmad, SA
    Bilimoria, MM
    Izzo, F
    Delrio, P
    Marra, P
    Baker, TP
    Porter, GA
    Ellis, LM
    Vauthey, JN
    Dhamotharan, S
    Curley, SA
    GASTROENTEROLOGY, 2000, 118 (04) : A1036 - A1036
  • [28] Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma
    Atta, Mohamed M.
    El-Masry, Samir A.
    Abdel-Hameed, Mohamed
    Baiomy, Hosam A.
    Ramadan, Naglaa E.
    CLINICAL BIOCHEMISTRY, 2008, 41 (14-15) : 1131 - 1139
  • [29] Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma
    Hao, Xinjie
    Xin, Ruopei
    Done, Wenjing
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (04)
  • [30] Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients
    El-Gebaly, Fatma
    Abou-saif, Sabry
    Elkadeem, Mahmoud
    Helmy, Amal
    Abd-Elsalam, Sherief
    Yousef, Mohamed
    Elkhouly, Reham Abdelkader
    Amer, Ibrahim Fathi
    El-Demerdash, Taher
    CURRENT CANCER DRUG TARGETS, 2019, 19 (11) : 896 - 905
12345